Vistagen Therapeutics, Inc. (VTGN)
0.1945
+0.01
(+3.46%)
USD |
NASDAQ |
Nov 18, 16:00
0.206
+0.01
(+5.91%)
After-Hours: 19:20
Vistagen Therapeutics Price to Book Value : 0.5915 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 0.5717 |
| November 16, 2026 | 0.5605 |
| November 13, 2026 | 0.5489 |
| November 12, 2026 | 0.5437 |
| November 11, 2026 | 0.5711 |
| November 10, 2026 | 0.5568 |
| November 09, 2026 | 0.5608 |
| November 06, 2026 | 0.4981 |
| November 05, 2026 | 0.5024 |
| November 04, 2026 | 0.5605 |
| November 03, 2026 | 0.5109 |
| November 02, 2026 | 0.5094 |
| October 30, 2026 | 0.5118 |
| October 29, 2026 | 0.5191 |
| October 28, 2026 | 0.517 |
| October 27, 2026 | 0.5291 |
| October 26, 2026 | 0.5285 |
| October 23, 2026 | 0.5465 |
| October 22, 2026 | 0.5687 |
| October 21, 2026 | 0.5887 |
| October 20, 2026 | 0.6015 |
| October 19, 2026 | 0.6176 |
| October 16, 2026 | 0.6082 |
| October 15, 2026 | 0.6477 |
| October 14, 2026 | 0.6283 |
| Date | Value |
|---|---|
| October 13, 2026 | 0.6532 |
| October 12, 2026 | 0.6891 |
| October 09, 2026 | 0.718 |
| October 08, 2026 | 0.7487 |
| October 07, 2026 | 0.7514 |
| October 06, 2026 | 0.7621 |
| October 05, 2026 | 0.8004 |
| October 02, 2026 | 0.8545 |
| October 01, 2026 | 0.8594 |
| September 30, 2026 | 0.936 |
| September 29, 2026 | 0.5402 |
| September 28, 2026 | 0.5384 |
| September 25, 2026 | 0.4949 |
| September 24, 2026 | 0.5348 |
| September 23, 2026 | 0.6679 |
| September 22, 2026 | 0.4558 |
| September 21, 2026 | 0.4224 |
| September 18, 2026 | 0.4351 |
| September 17, 2026 | 0.4235 |
| September 16, 2026 | 0.4181 |
| September 15, 2026 | 0.428 |
| September 14, 2026 | 0.4409 |
| September 11, 2026 | 0.4297 |
| September 10, 2026 | 0.4333 |
| September 09, 2026 | 0.4269 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Onconetix, Inc. | 0.0887 |
| ACADIA Pharmaceuticals, Inc. | 2.221 |
| Alnylam Pharmaceuticals, Inc. | 5.553 |
| Anika Therapeutics, Inc. | 1.326 |
| Savara, Inc. | 9.024 |
Price to Book Value Related Metrics
| PS Ratio | 3.455 |
| Price | 0.1945 |
| Earnings Yield | -721.4% |
| Market Cap | 8.867M |